ID

44089

Description

http://clinicaltrials.gov/ct2/show/NCT01657604

Lien

http://clinicaltrials.gov/ct2/show/NCT01657604

Mots-clés

Versions (3)
  1. 10/01/2014 10/01/2014 -
  2. 15/03/2021 15/03/2021 - Dr. rer. medic Philipp Neuhaus
  3. 20/09/2021 20/09/2021 -
Téléchargé le

20 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Bogen 2 Verlaufsbogen Seite 1 von 2 DRKS00005243 NCT01657604 Chronic Myeloid Leukemia

Allemand Anglais

Bogen 2 Verlaufsbogen Seite 1 von 2

1 Formulaires  
  1. StudyEvent: Bogen 2 Verlaufsbogen Seite 1 von 2
    1. Bogen 2 Verlaufsbogen Seite 1 von 2
Administrative Items
Description

Administrative Items

Hospital Identifier
Description

Klinik-Nr.

Type de données

integer

Alias
Code-1
Identifier
UMLS CUI 2011AB
C0600091
SNOMEDCT_2012_01_31
118522005
Code-2
Hospitals
UMLS CUI 2011AB
C0019994
LOINC Version 232
MTHU002722
Patient identifier
Description

Patienten-Nr.

Type de données

integer

Alias
Code-1
Identifier
UMLS CUI 2011AB
C0600091
SNOMEDCT_2012_01_31
118522005
Code-2
Patients
UMLS CUI 2011AB
C0030705
SNOMEDCT_2012_01_31
116154003
Date of birth
Description

Date of birth

Month of birth
Description

Geburtsmonat

Type de données

integer

Alias
Code-1
month
UMLS CUI 2011AB
C0439231
SNOMEDCT_2012_01_31
258706009
HL7 V3 2006_05
MO
Day of birth
Description

Geburtstag

Type de données

integer

Alias
Code-1
day
UMLS CUI 2011AB
C0439228
SNOMEDCT_2012_01_31
258703001
LOINC Version 232
MTHU039849
HL7 V3 2006_05
D
Administrative Items
Description

Administrative Items

Date of Evaluation
Description

Beurteilungsdatum

Type de données

date

Alias
Code-1
Evaluation
UMLS CUI 2011AB
C0220825
Code-2
Date in time
UMLS CUI 2011AB
C0011008
SNOMEDCT_2012_01_31
410671006
LOINC Version 232
MTHU021546
Number Follow-Up Report
Description

Nummer des Verlaufsbogen

Type de données

integer

Alias
Code-1
Follow-Up Report
UMLS CUI 2011AB
C1704685
Code-2
Numbers
UMLS CUI 2011AB
C0237753
SNOMEDCT_2012_01_31
410680006
LOINC Version 232
MTHU024869
Sex
Description

Geschlecht

Type de données

integer

Alias
Code-1
Patient sex
UMLS CUI 2011AB
C0150831
SNOMEDCT_2012_01_31
184100006
Therapy Phase
Description

Therapy Phase

Achievement goal of therapy of induction phase (after min. 2 years treatment) - date
Description

Erreichen des Therapiezieles der Induktionsphase (nach mindestens 24 Monaten Behandlung und 2-facher MMR) am:

Type de données

date

Alias
Code-1
Achievement
UMLS CUI 2011AB
C0001072
Code-2
treatment goals
UMLS CUI 2011AB
C0679840
Code-3
Induction
UMLS CUI 2011AB
C0857127
MedDRA 14.1
10021721
Code-4
Phase
UMLS CUI 2011AB
C0205390
SNOMEDCT_2012_01_31
21191007
Code-5
Post
UMLS CUI 2011AB
C0231290
SNOMEDCT_2012_01_31
255234002
Code-6
Minimum
UMLS CUI 2011AB
C1524031
Date Nilotinib treatment stopped in combination treatment arm
Description

Absetzdatum von Nilotinib im Kombinationsarm am:

Type de données

date

Alias
Code-1
Date treatment stopped (observable entity)
UMLS CUI 2011AB
C1531784
SNOMEDCT_2012_01_31
413947000
Code-2
Nilotinib
UMLS CUI 2011AB
C1721377
SNOMEDCT_2012_01_31
428468009
Code-3
Combination
UMLS CUI 2011AB
C1947911
Code-4
Protocol Treatment Arm
UMLS CUI 2011AB
C1522541
Achievement main phase (after min. 1 year treatment) - date
Description

Erreichen der Hauptphase (nach mindestens 12 Monaten Behandlung und mindestens 12 Monaten kontinuierlicher MR4) am:

Type de données

date

Alias
Code-1
Achievement
UMLS CUI 2011AB
C0001072
Code-2
Main
UMLS CUI 2011AB
C1542147
Code-3
Phase
UMLS CUI 2011AB
C0205390
SNOMEDCT_2012_01_31
21191007
Code-4
Post
UMLS CUI 2011AB
C0231290
SNOMEDCT_2012_01_31
255234002
Code-5
Minimum
UMLS CUI 2011AB
C1524031
Code-6
One
UMLS CUI 2011AB
C0205447
SNOMEDCT_2012_01_31
421379005
Date main phase treatment stopped
Description

Absetzdatum der Hauptphasentherapie am:

Type de données

date

Alias
Code-1
Date treatment stopped (observable entity)
UMLS CUI 2011AB
C1531784
SNOMEDCT_2012_01_31
413947000
Code-2
Main
UMLS CUI 2011AB
C1542147
Code-3
Phase
UMLS CUI 2011AB
C0205390
SNOMEDCT_2012_01_31
21191007
Code-4
Therapeutic procedure
UMLS CUI 2011AB
C0087111
SNOMEDCT_2012_01_31
277132007
MedDRA 14.1
10053757
LOINC Version 232
MTHU021209
Previous therapy within the interval
Description

Previous therapy within the interval

Nilotinib 2*300mg
Description

Nilotinib 2*300mg

other dosage (mg)
Description

andere Dosis (mg)

Type de données

integer

Alias
Code-1
Other
UMLS CUI 2011AB
C0205394
SNOMEDCT_2012_01_31
74964007
Code-2
Dosage
UMLS CUI 2011AB
C0178602
SNOMEDCT_2012_01_31
260911001
Code-3
Milligram
UMLS CUI 2011AB
C0439210
SNOMEDCT_2012_01_31
258684004
Start
Description

Beginn

Type de données

date

Alias
Code-1
Date treatment started (observable entity)
UMLS CUI 2011AB
C3173309
SNOMEDCT_2012_01_31
413946009
Code-2
Nilotinib
UMLS CUI 2011AB
C1721377
SNOMEDCT_2012_01_31
427941004
Code-3
Twice
UMLS CUI 2011AB
C1948050
Code-4
Three
UMLS CUI 2011AB
C0205449
SNOMEDCT_2012_01_31
421291004
Code-5
One Hundred
UMLS CUI 2011AB
CL447292
Code-6
Milligram
UMLS CUI 2011AB
C0439210
SNOMEDCT_2012_01_31
258684004
End
Description

Ende

Type de données

date

Alias
Code-1
Date treatment stopped (observable entity)
UMLS CUI 2011AB
C1531784
SNOMEDCT_2012_01_31
413947000
Code-2
Nilotinib
UMLS CUI 2011AB
C1721377
SNOMEDCT_2012_01_31
427941004
Code-3
Twice
UMLS CUI 2011AB
C1948050
Code-4
Three
UMLS CUI 2011AB
C0205449
SNOMEDCT_2012_01_31
421291004
Code-5
One Hundred
UMLS CUI 2011AB
CL447292
Code-6
Milligram
UMLS CUI 2011AB
C0439210
SNOMEDCT_2012_01_31
258684004
Days of treatment
Description

Therapietage

Type de données

integer

Alias
Code-1
Number
UMLS CUI 2011AB
C0449788
SNOMEDCT_2012_01_31
410681005
Code-2
Therapeutic procedure
UMLS CUI 2011AB
C0087111
SNOMEDCT_2012_01_31
277132007
MedDRA 14.1
10053757
LOINC Version 232
MTHU021209
Code-3
day
UMLS CUI 2011AB
C0439228
SNOMEDCT_2012_01_31
258703001
LOINC Version 232
MTHU039849
HL7 V3 2006_05
D
Code-4
Nilotinib
UMLS CUI 2011AB
C1721377
SNOMEDCT_2012_01_31
427941004
Code-5
Twice
UMLS CUI 2011AB
C1948050
Code-6
Three
UMLS CUI 2011AB
C0205449
SNOMEDCT_2012_01_31
421291004
Cumulative Dose (mg)
Description

Gesamtdosis (mg)

Type de données

integer

Alias
Code-1
Cumulative Dose
UMLS CUI 2011AB
C2986497
Code-2
Milligram
UMLS CUI 2011AB
C0439210
SNOMEDCT_2012_01_31
258684004
Code-3
Nilotinib
UMLS CUI 2011AB
C1721377
SNOMEDCT_2012_01_31
427941004
Code-4
Twice
UMLS CUI 2011AB
C1948050
Code-5
Three
UMLS CUI 2011AB
C0205449
SNOMEDCT_2012_01_31
421291004
Code-6
One Hundred
UMLS CUI 2011AB
CL447292
Treatment stop
Description

Absetzen

Type de données

integer

Alias
Code-1
Stop
UMLS CUI 2011AB
C1947925
Code-2
Nilotinib
UMLS CUI 2011AB
C1721377
SNOMEDCT_2012_01_31
427941004
Code-3
Twice
UMLS CUI 2011AB
C1948050
Code-4
Three
UMLS CUI 2011AB
C0205449
SNOMEDCT_2012_01_31
421291004
Code-5
One Hundred
UMLS CUI 2011AB
CL447292
Code-6
Milligram
UMLS CUI 2011AB
C0439210
SNOMEDCT_2012_01_31
258684004
Reason for treatment stop
Description

Grund für Absetzen

Type de données

integer

Alias
Code-1
Indication of (contextual qualifier)
UMLS CUI 2011AB
C0392360
SNOMEDCT_2012_01_31
410666004
LOINC Version 232
MTHU008319
Code-2
Stop
UMLS CUI 2011AB
C1947925
Code-3
Nilotinib
UMLS CUI 2011AB
C1721377
SNOMEDCT_2012_01_31
427941004
Code-4
Twice
UMLS CUI 2011AB
C1948050
Code-5
Three
UMLS CUI 2011AB
C0205449
SNOMEDCT_2012_01_31
421291004
Code-6
One Hundred
UMLS CUI 2011AB
CL447292
Reason for treatment stop
Description

Grund für Absetzen

Type de données

string

Alias
Code-1
Indication of (contextual qualifier)
UMLS CUI 2011AB
C0392360
SNOMEDCT_2012_01_31
410666004
LOINC Version 232
MTHU008319
Code-2
Stop
UMLS CUI 2011AB
C1947925
Code-3
Free Text Format
UMLS CUI 2011AB
C2348713
Code-4
Nilotinib
UMLS CUI 2011AB
C1721377
SNOMEDCT_2012_01_31
427941004
Code-5
Twice
UMLS CUI 2011AB
C1948050
Code-6
Three
UMLS CUI 2011AB
C0205449
SNOMEDCT_2012_01_31
421291004
Nilotinib - Rest
Description

Nilotinib - Rest

Start
Description

Beginn

Type de données

date

Alias
Code-1
Start Date
UMLS CUI 2011AB
C0808070
LOINC Version 232
MTHU008298
End
Description

Ende

Type de données

date

Alias
Code-1
End Date
UMLS CUI 2011AB
C0806020
LOINC Version 232
MTHU008302
PEG-IFN
Description

PEG-IFN

Start
Description

Beginn

Type de données

date

Alias
Code-1
Date treatment started (observable entity)
UMLS CUI 2011AB
C3173309
SNOMEDCT_2012_01_31
413946009
Code-2
Pegylated Interferon Alfa
UMLS CUI 2011AB
C0907160
End
Description

Ende

Type de données

date

Alias
Code-1
Date treatment stopped (observable entity)
UMLS CUI 2011AB
C1531784
SNOMEDCT_2012_01_31
413947000
Code-2
Pegylated Interferon Alfa
UMLS CUI 2011AB
C0907160
Single dose (μg)
Description

Einzeldosis (μg)

Type de données

integer

Alias
Code-1
Single dose characteristic (observable entity)
UMLS CUI 2011AB
C1960417
SNOMEDCT_2012_01_31
426146003
Code-2
Microgram
UMLS CUI 2011AB
C0439211
SNOMEDCT_2012_01_31
258685003
Intervall (days)
Description

Intervall (Tage)

Type de données

integer

Alias
Code-1
Interval
UMLS CUI 2011AB
C1272706
SNOMEDCT_2012_01_31
385673002
Number of Injections
Description

Anzahl Injektionen

Type de données

integer

Alias
Code-1
Number
UMLS CUI 2011AB
C0449788
SNOMEDCT_2012_01_31
410681005
Code-2
Injection procedure
UMLS CUI 2011AB
C1533685
SNOMEDCT_2012_01_31
129326001
MedDRA 14.1
10052995
Treatment stop
Description

Absetzen

Type de données

integer

Alias
Code-1
Stop
UMLS CUI 2011AB
C1947925
Code-2
Pegylated Interferon Alfa
UMLS CUI 2011AB
C0907160
Reason for treatment stop
Description

Grund für Absetzen

Type de données

integer

Alias
Code-1
Indication of (contextual qualifier)
UMLS CUI 2011AB
C0392360
SNOMEDCT_2012_01_31
410666004
LOINC Version 232
MTHU008319
Code-2
Stop
UMLS CUI 2011AB
C1947925
Code-3
Pegylated Interferon Alfa
UMLS CUI 2011AB
C0907160
Reason for treatment stop
Description

Grund für Absetzen

Type de données

string

Alias
Code-1
Indication of (contextual qualifier)
UMLS CUI 2011AB
C0392360
SNOMEDCT_2012_01_31
410666004
LOINC Version 232
MTHU008319
Code-2
Stop
UMLS CUI 2011AB
C1947925
Code-3
Free Text Format
UMLS CUI 2011AB
C2348713
Code-4
Pegylated Interferon Alfa
UMLS CUI 2011AB
C0907160
PEG-IFN - Rest
Description

PEG-IFN - Rest

Start
Description

Beginn

Type de données

date

Alias
Code-1
Start Date
UMLS CUI 2011AB
C0808070
LOINC Version 232
MTHU008298
Code-2
Pegylated Interferon Alfa
UMLS CUI 2011AB
C0907160
Code-3
Rest
UMLS CUI 2011AB
C0035253
SNOMEDCT_2012_01_31
258157001
End
Description

Ende

Type de données

date

Alias
Code-1
End Date
UMLS CUI 2011AB
C0806020
LOINC Version 232
MTHU008302
Code-2
Pegylated Interferon Alfa
UMLS CUI 2011AB
C0907160
Code-3
Rest
UMLS CUI 2011AB
C0035253
SNOMEDCT_2012_01_31
258157001
further drugs
Description

further drugs

Reason for further drug
Description

Grund

Type de données

string

Alias
Code-1
Indication of (contextual qualifier)
UMLS CUI 2011AB
C0392360
SNOMEDCT_2012_01_31
410666004
LOINC Version 232
MTHU008319
Code-2
Further
UMLS CUI 2011AB
C1517331
Code-3
Pharmaceutical Preparations
UMLS CUI 2011AB
C0013227
SNOMEDCT_2012_01_31
410942007
Drug
Description

Medikament

Type de données

string

Alias
Code-1
Pharmaceutical Preparations
UMLS CUI 2011AB
C0013227
SNOMEDCT_2012_01_31
410942007
Dosage
Description

Dosis

Type de données

integer

Alias
Code-1
Dosage
UMLS CUI 2011AB
C0178602
SNOMEDCT_2012_01_31
277406006
Unit
Description

Einheit

Type de données

string

Alias
Code-1
Dosage Form Unit
UMLS CUI 2011AB
C2348328
Start
Description

Beginn

Type de données

date

Alias
Code-1
Date treatment started (observable entity)
UMLS CUI 2011AB
C3173309
SNOMEDCT_2012_01_31
413946009
Code-2
Further
UMLS CUI 2011AB
C1517331
Code-3
Pharmaceutical Preparations
UMLS CUI 2011AB
C0013227
SNOMEDCT_2012_01_31
410942007
End
Description

Ende

Type de données

date

Alias
Code-1
Date treatment stopped (observable entity)
UMLS CUI 2011AB
C1531784
SNOMEDCT_2012_01_31
413947000
Code-2
Further
UMLS CUI 2011AB
C1517331
Code-3
Pharmaceutical Preparations
UMLS CUI 2011AB
C0013227
SNOMEDCT_2012_01_31
410942007
Signature
Description

Signature

Comment
Description

Kommentar

Type de données

string

Alias
Code-1
Comment
UMLS CUI 2011AB
C0947611
LOINC Version 232
MTHU013736
Hospital
Description

Klinik

Type de données

string

Alias
Code-1
Hospitals
UMLS CUI 2011AB
C0019994
LOINC Version 232
MTHU002722
Date
Description

Datum

Type de données

date

Alias
Code-1
Signature date
UMLS CUI 2011AB
C0807937
LOINC Version 232
MTHU008294
Signature
Description

Unterschrift

Type de données

string

Alias
Code-1
Investigator Signature
UMLS CUI 2011AB
C2346576
Retour au début de la page

Similar models

Bogen 2 Verlaufsbogen Seite 1 von 2

1 Formulaires
  1. StudyEvent: Bogen 2 Verlaufsbogen Seite 1 von 2
    1. Bogen 2 Verlaufsbogen Seite 1 von 2
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Administrative Items
Klinik-Nr.
Item
Hospital Identifier
integer
Identifier (Code-1)
C0600091 (UMLS CUI 2011AB)
118522005 (SNOMEDCT_2012_01_31)
Hospitals (Code-2)
C0019994 (UMLS CUI 2011AB)
MTHU002722 (LOINC Version 232)
Patienten-Nr.
Item
Patient identifier
integer
Identifier (Code-1)
C0600091 (UMLS CUI 2011AB)
118522005 (SNOMEDCT_2012_01_31)
Patients (Code-2)
C0030705 (UMLS CUI 2011AB)
116154003 (SNOMEDCT_2012_01_31)
Item Group
Date of birth
Geburtsmonat
Item
Month of birth
integer
month (Code-1)
C0439231 (UMLS CUI 2011AB)
258706009 (SNOMEDCT_2012_01_31)
MO (HL7 V3 2006_05)
Geburtstag
Item
Day of birth
integer
day (Code-1)
C0439228 (UMLS CUI 2011AB)
258703001 (SNOMEDCT_2012_01_31)
MTHU039849 (LOINC Version 232)
D (HL7 V3 2006_05)
Item Group
Administrative Items
Beurteilungsdatum
Item
Date of Evaluation
date
Evaluation (Code-1)
C0220825 (UMLS CUI 2011AB)
Date in time (Code-2)
C0011008 (UMLS CUI 2011AB)
410671006 (SNOMEDCT_2012_01_31)
MTHU021546 (LOINC Version 232)
Nummer des Verlaufsbogen
Item
Number Follow-Up Report
integer
Follow-Up Report (Code-1)
C1704685 (UMLS CUI 2011AB)
Numbers (Code-2)
C0237753 (UMLS CUI 2011AB)
410680006 (SNOMEDCT_2012_01_31)
MTHU024869 (LOINC Version 232)
Item
Sex
integer
Patient sex (Code-1)
C0150831 (UMLS CUI 2011AB)
184100006 (SNOMEDCT_2012_01_31)
Geschlecht
Code List
Sex
CL Item
Male (männlich)
Male gender (Code-1)
C0086582 (UMLS CUI 2011AB)
10052007 (SNOMEDCT_2012_01_31)
CL Item
Female (weiblich)
C0086287 (UMLS CUI 2011AB)
1086007 (SNOMEDCT_2012_01_31)
Item Group
Therapy Phase
Erreichen des Therapiezieles der Induktionsphase (nach mindestens 24 Monaten Behandlung und 2-facher MMR) am:
Item
Achievement goal of therapy of induction phase (after min. 2 years treatment) - date
date
Achievement (Code-1)
C0001072 (UMLS CUI 2011AB)
treatment goals (Code-2)
C0679840 (UMLS CUI 2011AB)
Induction (Code-3)
C0857127 (UMLS CUI 2011AB)
10021721 (MedDRA 14.1)
Phase (Code-4)
C0205390 (UMLS CUI 2011AB)
21191007 (SNOMEDCT_2012_01_31)
Post (Code-5)
C0231290 (UMLS CUI 2011AB)
255234002 (SNOMEDCT_2012_01_31)
Minimum (Code-6)
C1524031 (UMLS CUI 2011AB)
Absetzdatum von Nilotinib im Kombinationsarm am:
Item
Date Nilotinib treatment stopped in combination treatment arm
date
Date treatment stopped (observable entity) (Code-1)
C1531784 (UMLS CUI 2011AB)
413947000 (SNOMEDCT_2012_01_31)
Nilotinib (Code-2)
C1721377 (UMLS CUI 2011AB)
428468009 (SNOMEDCT_2012_01_31)
Combination (Code-3)
C1947911 (UMLS CUI 2011AB)
Protocol Treatment Arm (Code-4)
C1522541 (UMLS CUI 2011AB)
Erreichen der Hauptphase (nach mindestens 12 Monaten Behandlung und mindestens 12 Monaten kontinuierlicher MR4) am:
Item
Achievement main phase (after min. 1 year treatment) - date
date
Achievement (Code-1)
C0001072 (UMLS CUI 2011AB)
Main (Code-2)
C1542147 (UMLS CUI 2011AB)
Phase (Code-3)
C0205390 (UMLS CUI 2011AB)
21191007 (SNOMEDCT_2012_01_31)
Post (Code-4)
C0231290 (UMLS CUI 2011AB)
255234002 (SNOMEDCT_2012_01_31)
Minimum (Code-5)
C1524031 (UMLS CUI 2011AB)
One (Code-6)
C0205447 (UMLS CUI 2011AB)
421379005 (SNOMEDCT_2012_01_31)
Absetzdatum der Hauptphasentherapie am:
Item
Date main phase treatment stopped
date
Date treatment stopped (observable entity) (Code-1)
C1531784 (UMLS CUI 2011AB)
413947000 (SNOMEDCT_2012_01_31)
Main (Code-2)
C1542147 (UMLS CUI 2011AB)
Phase (Code-3)
C0205390 (UMLS CUI 2011AB)
21191007 (SNOMEDCT_2012_01_31)
Therapeutic procedure (Code-4)
C0087111 (UMLS CUI 2011AB)
277132007 (SNOMEDCT_2012_01_31)
10053757 (MedDRA 14.1)
MTHU021209 (LOINC Version 232)
Item Group
Previous therapy within the interval
Item Group
Nilotinib 2*300mg
andere Dosis (mg)
Item
other dosage (mg)
integer
Other (Code-1)
C0205394 (UMLS CUI 2011AB)
74964007 (SNOMEDCT_2012_01_31)
Dosage (Code-2)
C0178602 (UMLS CUI 2011AB)
260911001 (SNOMEDCT_2012_01_31)
Milligram (Code-3)
C0439210 (UMLS CUI 2011AB)
258684004 (SNOMEDCT_2012_01_31)
Beginn
Item
Start
date
Date treatment started (observable entity) (Code-1)
C3173309 (UMLS CUI 2011AB)
413946009 (SNOMEDCT_2012_01_31)
Nilotinib (Code-2)
C1721377 (UMLS CUI 2011AB)
427941004 (SNOMEDCT_2012_01_31)
Twice (Code-3)
C1948050 (UMLS CUI 2011AB)
Three (Code-4)
C0205449 (UMLS CUI 2011AB)
421291004 (SNOMEDCT_2012_01_31)
One Hundred (Code-5)
CL447292 (UMLS CUI 2011AB)
Milligram (Code-6)
C0439210 (UMLS CUI 2011AB)
258684004 (SNOMEDCT_2012_01_31)
Ende
Item
End
date
Date treatment stopped (observable entity) (Code-1)
C1531784 (UMLS CUI 2011AB)
413947000 (SNOMEDCT_2012_01_31)
Nilotinib (Code-2)
C1721377 (UMLS CUI 2011AB)
427941004 (SNOMEDCT_2012_01_31)
Twice (Code-3)
C1948050 (UMLS CUI 2011AB)
Three (Code-4)
C0205449 (UMLS CUI 2011AB)
421291004 (SNOMEDCT_2012_01_31)
One Hundred (Code-5)
CL447292 (UMLS CUI 2011AB)
Milligram (Code-6)
C0439210 (UMLS CUI 2011AB)
258684004 (SNOMEDCT_2012_01_31)
Therapietage
Item
Days of treatment
integer
Number (Code-1)
C0449788 (UMLS CUI 2011AB)
410681005 (SNOMEDCT_2012_01_31)
Therapeutic procedure (Code-2)
C0087111 (UMLS CUI 2011AB)
277132007 (SNOMEDCT_2012_01_31)
10053757 (MedDRA 14.1)
MTHU021209 (LOINC Version 232)
day (Code-3)
C0439228 (UMLS CUI 2011AB)
258703001 (SNOMEDCT_2012_01_31)
MTHU039849 (LOINC Version 232)
D (HL7 V3 2006_05)
Nilotinib (Code-4)
C1721377 (UMLS CUI 2011AB)
427941004 (SNOMEDCT_2012_01_31)
Twice (Code-5)
C1948050 (UMLS CUI 2011AB)
Three (Code-6)
C0205449 (UMLS CUI 2011AB)
421291004 (SNOMEDCT_2012_01_31)
Gesamtdosis (mg)
Item
Cumulative Dose (mg)
integer
Cumulative Dose (Code-1)
C2986497 (UMLS CUI 2011AB)
Milligram (Code-2)
C0439210 (UMLS CUI 2011AB)
258684004 (SNOMEDCT_2012_01_31)
Nilotinib (Code-3)
C1721377 (UMLS CUI 2011AB)
427941004 (SNOMEDCT_2012_01_31)
Twice (Code-4)
C1948050 (UMLS CUI 2011AB)
Three (Code-5)
C0205449 (UMLS CUI 2011AB)
421291004 (SNOMEDCT_2012_01_31)
One Hundred (Code-6)
CL447292 (UMLS CUI 2011AB)
Item
Treatment stop
integer
Stop (Code-1)
C1947925 (UMLS CUI 2011AB)
Nilotinib (Code-2)
C1721377 (UMLS CUI 2011AB)
427941004 (SNOMEDCT_2012_01_31)
Twice (Code-3)
C1948050 (UMLS CUI 2011AB)
Three (Code-4)
C0205449 (UMLS CUI 2011AB)
421291004 (SNOMEDCT_2012_01_31)
One Hundred (Code-5)
CL447292 (UMLS CUI 2011AB)
Milligram (Code-6)
C0439210 (UMLS CUI 2011AB)
258684004 (SNOMEDCT_2012_01_31)
Absetzen
Code List
Treatment stop
CL Item
No (nein)
No (Code-1)
C1298908 (UMLS CUI 2011AB)
373067005 (SNOMEDCT_2012_01_31)
CL Item
Yes (ja)
Yes (Code-1)
C1298907 (UMLS CUI 2011AB)
373066001 (SNOMEDCT_2012_01_31)
Item
Reason for treatment stop
integer
Indication of (contextual qualifier) (Code-1)
C0392360 (UMLS CUI 2011AB)
410666004 (SNOMEDCT_2012_01_31)
MTHU008319 (LOINC Version 232)
Stop (Code-2)
C1947925 (UMLS CUI 2011AB)
Nilotinib (Code-3)
C1721377 (UMLS CUI 2011AB)
427941004 (SNOMEDCT_2012_01_31)
Twice (Code-4)
C1948050 (UMLS CUI 2011AB)
Three (Code-5)
C0205449 (UMLS CUI 2011AB)
421291004 (SNOMEDCT_2012_01_31)
One Hundred (Code-6)
CL447292 (UMLS CUI 2011AB)
Grund für Absetzen
Code List
Reason for treatment stop
CL Item
G=planned stop, course of treatment (G)
Stop (Code-1)
C1947925 (UMLS CUI 2011AB)
Plan (Code-2)
C1301732 (UMLS CUI 2011AB)
397943006 (SNOMEDCT_2012_01_31)
Course (Code-3)
C0750729 (UMLS CUI 2011AB)
288524001 (SNOMEDCT_2012_01_31)
Therapeutic procedure (Code-4)
C0087111 (UMLS CUI 2011AB)
277132007 (SNOMEDCT_2012_01_31)
10053757 (MedDRA 14.1)
MTHU021209 (LOINC Version 232)
CL Item
U=Intolerance (U)
Drug intolerance (Code-1)
C0277585 (UMLS CUI 2011AB)
59037007 (SNOMEDCT_2012_01_31)
10061822 (MedDRA 14.1)
DINT (HL7 V3 2006_05)
CL Item
A=Patient refused (A)
Treatment refused due to patient's wishes (Code-1)
C0852684 (UMLS CUI 2011AB)
10044558 (MedDRA 14.1)
CL Item
S=other (S)
Other (Code-1)
C0205394 (UMLS CUI 2011AB)
74964007 (SNOMEDCT_2012_01_31)
Grund für Absetzen
Item
Reason for treatment stop
string
Indication of (contextual qualifier) (Code-1)
C0392360 (UMLS CUI 2011AB)
410666004 (SNOMEDCT_2012_01_31)
MTHU008319 (LOINC Version 232)
Stop (Code-2)
C1947925 (UMLS CUI 2011AB)
Free Text Format (Code-3)
C2348713 (UMLS CUI 2011AB)
Nilotinib (Code-4)
C1721377 (UMLS CUI 2011AB)
427941004 (SNOMEDCT_2012_01_31)
Twice (Code-5)
C1948050 (UMLS CUI 2011AB)
Three (Code-6)
C0205449 (UMLS CUI 2011AB)
421291004 (SNOMEDCT_2012_01_31)
Item Group
Nilotinib - Rest
Beginn
Item
Start
date
Start Date (Code-1)
C0808070 (UMLS CUI 2011AB)
MTHU008298 (LOINC Version 232)
Ende
Item
End
date
End Date (Code-1)
C0806020 (UMLS CUI 2011AB)
MTHU008302 (LOINC Version 232)
Item Group
PEG-IFN
Beginn
Item
Start
date
Date treatment started (observable entity) (Code-1)
C3173309 (UMLS CUI 2011AB)
413946009 (SNOMEDCT_2012_01_31)
Pegylated Interferon Alfa (Code-2)
C0907160 (UMLS CUI 2011AB)
Ende
Item
End
date
Date treatment stopped (observable entity) (Code-1)
C1531784 (UMLS CUI 2011AB)
413947000 (SNOMEDCT_2012_01_31)
Pegylated Interferon Alfa (Code-2)
C0907160 (UMLS CUI 2011AB)
Einzeldosis (μg)
Item
Single dose (μg)
integer
Single dose characteristic (observable entity) (Code-1)
C1960417 (UMLS CUI 2011AB)
426146003 (SNOMEDCT_2012_01_31)
Microgram (Code-2)
C0439211 (UMLS CUI 2011AB)
258685003 (SNOMEDCT_2012_01_31)
Intervall (Tage)
Item
Intervall (days)
integer
Interval (Code-1)
C1272706 (UMLS CUI 2011AB)
385673002 (SNOMEDCT_2012_01_31)
Anzahl Injektionen
Item
Number of Injections
integer
Number (Code-1)
C0449788 (UMLS CUI 2011AB)
410681005 (SNOMEDCT_2012_01_31)
Injection procedure (Code-2)
C1533685 (UMLS CUI 2011AB)
129326001 (SNOMEDCT_2012_01_31)
10052995 (MedDRA 14.1)
Item
Treatment stop
integer
Stop (Code-1)
C1947925 (UMLS CUI 2011AB)
Pegylated Interferon Alfa (Code-2)
C0907160 (UMLS CUI 2011AB)
Absetzen
Code List
Treatment stop
CL Item
No (nein)
No (Code-1)
C1298908 (UMLS CUI 2011AB)
373067005 (SNOMEDCT_2012_01_31)
CL Item
Yes (ja)
Yes (Code-1)
C1298907 (UMLS CUI 2011AB)
373066001 (SNOMEDCT_2012_01_31)
Item
Reason for treatment stop
integer
Indication of (contextual qualifier) (Code-1)
C0392360 (UMLS CUI 2011AB)
410666004 (SNOMEDCT_2012_01_31)
MTHU008319 (LOINC Version 232)
Stop (Code-2)
C1947925 (UMLS CUI 2011AB)
Pegylated Interferon Alfa (Code-3)
C0907160 (UMLS CUI 2011AB)
Grund für Absetzen
Code List
Reason for treatment stop
CL Item
G=planned stop, course of treatment (G)
Stop (Code-1)
C1947925 (UMLS CUI 2011AB)
Plan (Code-2)
C1301732 (UMLS CUI 2011AB)
397943006 (SNOMEDCT_2012_01_31)
Course (Code-3)
C0750729 (UMLS CUI 2011AB)
288524001 (SNOMEDCT_2012_01_31)
Therapeutic procedure (Code-4)
C0087111 (UMLS CUI 2011AB)
277132007 (SNOMEDCT_2012_01_31)
10053757 (MedDRA 14.1)
MTHU021209 (LOINC Version 232)
CL Item
U=Intolerance (U)
Drug intolerance (Code-1)
C0277585 (UMLS CUI 2011AB)
59037007 (SNOMEDCT_2012_01_31)
10061822 (MedDRA 14.1)
DINT (HL7 V3 2006_05)
CL Item
A=Patient refused (A)
Treatment refused due to patient's wishes (Code-1)
C0852684 (UMLS CUI 2011AB)
10044558 (MedDRA 14.1)
CL Item
S=other (S)
Other (Code-1)
C0205394 (UMLS CUI 2011AB)
74964007 (SNOMEDCT_2012_01_31)
Grund für Absetzen
Item
Reason for treatment stop
string
Indication of (contextual qualifier) (Code-1)
C0392360 (UMLS CUI 2011AB)
410666004 (SNOMEDCT_2012_01_31)
MTHU008319 (LOINC Version 232)
Stop (Code-2)
C1947925 (UMLS CUI 2011AB)
Free Text Format (Code-3)
C2348713 (UMLS CUI 2011AB)
Pegylated Interferon Alfa (Code-4)
C0907160 (UMLS CUI 2011AB)
Item Group
PEG-IFN - Rest
Beginn
Item
Start
date
Start Date (Code-1)
C0808070 (UMLS CUI 2011AB)
MTHU008298 (LOINC Version 232)
Pegylated Interferon Alfa (Code-2)
C0907160 (UMLS CUI 2011AB)
Rest (Code-3)
C0035253 (UMLS CUI 2011AB)
258157001 (SNOMEDCT_2012_01_31)
Ende
Item
End
date
End Date (Code-1)
C0806020 (UMLS CUI 2011AB)
MTHU008302 (LOINC Version 232)
Pegylated Interferon Alfa (Code-2)
C0907160 (UMLS CUI 2011AB)
Rest (Code-3)
C0035253 (UMLS CUI 2011AB)
258157001 (SNOMEDCT_2012_01_31)
Item Group
further drugs
Grund
Item
Reason for further drug
string
Indication of (contextual qualifier) (Code-1)
C0392360 (UMLS CUI 2011AB)
410666004 (SNOMEDCT_2012_01_31)
MTHU008319 (LOINC Version 232)
Further (Code-2)
C1517331 (UMLS CUI 2011AB)
Pharmaceutical Preparations (Code-3)
C0013227 (UMLS CUI 2011AB)
410942007 (SNOMEDCT_2012_01_31)
Medikament
Item
Drug
string
Pharmaceutical Preparations (Code-1)
C0013227 (UMLS CUI 2011AB)
410942007 (SNOMEDCT_2012_01_31)
Dosis
Item
Dosage
integer
Dosage (Code-1)
C0178602 (UMLS CUI 2011AB)
277406006 (SNOMEDCT_2012_01_31)
Einheit
Item
Unit
string
Dosage Form Unit (Code-1)
C2348328 (UMLS CUI 2011AB)
Beginn
Item
Start
date
Date treatment started (observable entity) (Code-1)
C3173309 (UMLS CUI 2011AB)
413946009 (SNOMEDCT_2012_01_31)
Further (Code-2)
C1517331 (UMLS CUI 2011AB)
Pharmaceutical Preparations (Code-3)
C0013227 (UMLS CUI 2011AB)
410942007 (SNOMEDCT_2012_01_31)
Ende
Item
End
date
Date treatment stopped (observable entity) (Code-1)
C1531784 (UMLS CUI 2011AB)
413947000 (SNOMEDCT_2012_01_31)
Further (Code-2)
C1517331 (UMLS CUI 2011AB)
Pharmaceutical Preparations (Code-3)
C0013227 (UMLS CUI 2011AB)
410942007 (SNOMEDCT_2012_01_31)
Item Group
Signature
Kommentar
Item
Comment
string
Comment (Code-1)
C0947611 (UMLS CUI 2011AB)
MTHU013736 (LOINC Version 232)
Klinik
Item
Hospital
string
Hospitals (Code-1)
C0019994 (UMLS CUI 2011AB)
MTHU002722 (LOINC Version 232)
Datum
Item
Date
date
Signature date (Code-1)
C0807937 (UMLS CUI 2011AB)
MTHU008294 (LOINC Version 232)
Unterschrift
Item
Signature
string
Investigator Signature (Code-1)
C2346576 (UMLS CUI 2011AB)
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial